Rachel Rennard

710 total citations
18 papers, 512 citations indexed

About

Rachel Rennard is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rachel Rennard has authored 18 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rachel Rennard's work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and HER2/EGFR in Cancer Research (4 papers). Rachel Rennard is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and HER2/EGFR in Cancer Research (4 papers). Rachel Rennard collaborates with scholars based in United States. Rachel Rennard's co-authors include Alan M. Lambowitz, Thomas J. Sferra, Neeraj Kohli, Lihui Xu, Yang Jiao, Alexey A. Lugovskoy, Georg Mohr, Lourdes Pablo, Véronique Bailly and Steven D. Miklasz and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Rachel Rennard

18 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Rennard United States 12 284 128 127 115 78 18 512
Karen E. Strunk United States 10 339 1.2× 215 1.7× 219 1.7× 88 0.8× 47 0.6× 11 657
Fabian Richter Germany 13 213 0.8× 130 1.0× 129 1.0× 176 1.5× 33 0.4× 23 455
Bangmin Zhu United States 10 468 1.6× 258 2.0× 142 1.1× 69 0.6× 23 0.3× 15 717
Lucio Gómez Spain 10 286 1.0× 323 2.5× 237 1.9× 47 0.4× 38 0.5× 14 667
Franziska Lang Germany 9 365 1.3× 274 2.1× 212 1.7× 62 0.5× 40 0.5× 16 553
Amy Heidersbach United States 12 864 3.0× 90 0.7× 89 0.7× 41 0.4× 43 0.6× 17 1.0k
Jonathan Skupsky United States 13 129 0.5× 220 1.7× 72 0.6× 65 0.6× 31 0.4× 27 509
Feng‐Ting Huang Taiwan 11 383 1.3× 250 2.0× 77 0.6× 52 0.5× 23 0.3× 14 616
Trevor M. Twose United Kingdom 5 124 0.4× 215 1.7× 45 0.4× 126 1.1× 33 0.4× 9 429
André Engling Germany 7 237 0.8× 205 1.6× 71 0.6× 39 0.3× 60 0.8× 10 517

Countries citing papers authored by Rachel Rennard

Since Specialization
Citations

This map shows the geographic impact of Rachel Rennard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Rennard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Rennard more than expected).

Fields of papers citing papers by Rachel Rennard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Rennard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Rennard. The network helps show where Rachel Rennard may publish in the future.

Co-authorship network of co-authors of Rachel Rennard

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Rennard. A scholar is included among the top collaborators of Rachel Rennard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Rennard. Rachel Rennard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nguyen, Hien Thi Thu, Michael L. De Ieso, Ian E. Brown, et al.. (2024). ANGPTL7 and Its Role in IOP and Glaucoma. Investigative Ophthalmology & Visual Science. 65(3). 22–22. 6 indexed citations
2.
Eskiocak, Uğur, Thomas J. Daly, Allison Nelson, et al.. (2019). Abstract 3239: CTX-5861 mediated SIRPα blockade combines with tumor targeting antibodies, checkpoint blockade and/or CD137 agonism to elicit curative anti-tumor activity in syngeneic mouse models. Cancer Research. 79(13_Supplement). 3239–3239. 2 indexed citations
3.
Kopesky, Paul W., Rachel Rennard, Neeraj Kohli, et al.. (2017). A cartilage-targeted insulin-like growth factor-1 is retained in cartilage and promotes extracellular matrix maintenance in rat medial meniscus tear model. Osteoarthritis and Cartilage. 25. S53–S54. 1 indexed citations
4.
Geddie, Melissa L., Neeraj Kohli, Dmitri B. Kirpotin, et al.. (2016). Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting. mAbs. 9(1). 58–67. 24 indexed citations
5.
Zhang, Kathy, Melissa L. Geddie, Neeraj Kohli, et al.. (2014). Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle. mAbs. 7(1). 42–52. 27 indexed citations
6.
Fitzgerald, Jonathan B., Bryan W. Johnson, Jason Baum, et al.. (2013). MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors. Molecular Cancer Therapeutics. 13(2). 410–425. 87 indexed citations
7.
Xu, Lihui, Neeraj Kohli, Rachel Rennard, et al.. (2013). Rapid optimization and prototyping for therapeutic antibody-like molecules. mAbs. 5(2). 237–254. 21 indexed citations
8.
Baum, Jason, Bryan W. Johnson, Sharlene Adams, et al.. (2012). Abstract 2719: MM-141, a novel bispecific antibody co-targeting IGF-1R and ErbB3, blocks ligand-induced signaling and demonstrates antitumor activity. Cancer Research. 72(8_Supplement). 2719–2719. 3 indexed citations
9.
Lugovskoy, Alexey A., Bryan W. Johnson, Jason Baum, et al.. (2011). Abstract B205: Therapeutically targeting redundant, growth factor-induced prosurvival signaling with MM-141, a novel bispecific antibody targeting IGF-1R and ErbB3.. Molecular Cancer Therapeutics. 10(11_Supplement). B205–B205. 2 indexed citations
10.
Cho, Samuel K., Yan Ren, Ling Ling Chen, et al.. (2010). Antibodies directed to α6β4 highlight the adhesive and signaling functions of the integrin in breast cancer cell lines. Cancer Biology & Therapy. 9(6). 437–445. 5 indexed citations
11.
Sizing, Irene, Véronique Bailly, Patricia McCoon, et al.. (2007). Epitope-Dependent Effect of Anti-Murine TIM-1 Monoclonal Antibodies on T Cell Activity and Lung Immune Responses. The Journal of Immunology. 178(4). 2249–2261. 66 indexed citations
12.
Rennert, Paul D., Takaharu Ichimura, Irene Sizing, et al.. (2006). T Cell, Ig Domain, Mucin Domain-2 Gene-Deficient Mice Reveal a Novel Mechanism for the Regulation of Th2 Immune Responses and Airway Inflammation. The Journal of Immunology. 177(7). 4311–4321. 64 indexed citations
13.
Sferra, Thomas J., et al.. (2004). Widespread Correction of Lysosomal Storage Following Intrahepatic Injection of a Recombinant Adeno-associated Virus in the Adult MPS VII Mouse. Molecular Therapy. 10(3). 478–491. 44 indexed citations
15.
Sferra, Thomas J., Guang Qu, David L. McNeely, et al.. (2000). Recombinant Adeno-Associated Virus-Mediated Correction of Lysosomal Storage within the Central Nervous System of the Adult Mucopolysaccharidosis Type VII Mouse. Human Gene Therapy. 11(4). 507–519. 55 indexed citations
16.
Wallweber, Gerald, Sabine Mohr, Rachel Rennard, Mark G. Caprara, & Alan M. Lambowitz. (1997). Characterization of Neurospora mitochondrial group I introns reveals different CYT-18 dependent and independent splicing strategies and an alternative 3' splice site for an intron ORF.. PubMed. 3(2). 114–31. 29 indexed citations
17.
Myers, Christopher A., Gerald Wallweber, Rachel Rennard, et al.. (1996). A Tyrosyl-tRNA Synthetase Suppresses Structural Defects in the Two Major Helical Domains of the Group I Intron Catalytic Core. Journal of Molecular Biology. 262(2). 87–104. 27 indexed citations
18.
Szaniszlo, Paul J., et al.. (1993). Cell cycle regulation of polymorphism in Wangiella dermatitidis.. PubMed. 24(3). 251–61. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026